We are live on
!
Find out more
Winton Group Portfolio holdings
AUM
$3.09B
Turnover
59.06%
1-Year Est. Return
40.4%
This Fund
S&P 500
This Quarter
Est. Return
+13.28%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.71%
AUM
$1.75B
AUM Growth
+$368M
(+27%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
12.52%
Top 10 Holdings %
Top 10 Hldgs %
21.43%
Holding
1,497
New
198
Increased
649
Reduced
507
Closed
137
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$38.1M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$34.4M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$31.7M |
| 4 |
iShares MBS ETF
MBB
|
+$24.8M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$18.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$13.1M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$9.87M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$9.33M |
| 4 |
Apple
AAPL
|
+$7.81M |
| 5 |
Trex
TREX
|
+$5.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.12% |
| 2 | Financials | 16.02% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Technology | 11.56% |
| 5 | Healthcare | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EMAN
1326
DELISTED
eMagin Corporation
EMAN
| $123K | 0.01% |
32,898
+7,965
| +32% | +$26.8K |
2020 Q4
1 quarter
|
|
1327
Tempest Therapeutics
TPST
$10.7M
| $112K | 0.01% |
479
+91
| +23% | +$36.8K |
2020 Q3
2 quarters
|
|
1328
DELISTED
Assertio
ASRT
| $109K | 0.01% |
2,669
-304
| -10% | -$15.1K |
2019 Q4
5 quarters
|
|
1329
eGain
EGAN
$146M
| $107K | 0.01% |
+11,300
| New | +$126K |
2021 Q1
0 quarters
|
|
1330
DELISTED
Trevena, Inc.
TRVN
| $105K | 0.01% |
94
+2
| +2% | +$2.77K |
2019 Q3
6 quarters
|
|
1331
Lineage Cell Therapeutics
LCTX
$250M
| $103K | 0.01% |
44,013
+9,242
| +27% | +$22.2K |
2019 Q4
5 quarters
|
|
1332
Reading International Class A
RDI
$41M
| $103K | 0.01% |
18,568
-1,135
| -6% | -$7.56K |
2019 Q3
6 quarters
|
|
1333
SunCoke Energy
SXC
$864M
| $101K | 0.01% |
+14,366
| New | +$88.7K |
2021 Q1
0 quarters
|
|
|
TREC
1334
DELISTED
Trecora Resources
TREC
| $100K | 0.01% |
12,857
+2,656
| +26% | +$19.3K |
2019 Q3
6 quarters
|
|
|
STSA
1335
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $99K | 0.01% |
16,793
+4,882
| +41% | +$29.6K |
2020 Q4
1 quarter
|
|
1336
McEwen Inc
MUX
$995M
| $97K | 0.01% |
9,347
-3,711
| -28% | -$40.7K |
2019 Q1
8 quarters
|
|
1337
Matinas BioPharma
MTNB
$2.37M
| $93K | 0.01% |
118
-10
| -8% | -$10.1K |
2019 Q3
6 quarters
|
|
1338
Lite Strategy Inc
LITS
$36.3M
| $90K | 0.01% |
1,306
-45
| -3% | -$3.15K |
2019 Q3
6 quarters
|
|
1339
cbdMD
YCBD
$4.03M
| $88K | 0.01% |
59
-15
| -20% | -$21.8K |
2020 Q3
2 quarters
|
|
1340
Amneal Pharmaceuticals
AMRX
$6.7B
| $84K | ﹤0.01% |
+12,536
| New | +$69.5K |
2021 Q1
0 quarters
|
|
|
ZSAN
1341
DELISTED
Zosano Pharma Corporation
ZSAN
| $80K | ﹤0.01% |
1,845
-66
| -3% | -$2.76K |
2020 Q2
3 quarters
|
|
1342
Geron
GERN
$790M
| $73K | ﹤0.01% |
46,258
+16,745
| +57% | +$29.9K |
2020 Q2
3 quarters
|
|
1343
Ramaco Resources Class A
METC
$531M
| $69K | ﹤0.01% |
16,938
-2,229
| -12% | -$8.46K |
2020 Q2
3 quarters
|
|
1344
TPG Mortgage Investment Trust
MITT
$176M
| $67K | ﹤0.01% |
5,503
-13,564
| -71% | -$154K |
2018 Q1
12 quarters
|
|
1345
Pulmatrix
PULM
$5.15M
| $67K | ﹤0.01% |
2,517
+661
| +36% | +$20.2K |
2020 Q3
2 quarters
|
|
1346
Universal Technical Institute
UTI
$1.13B
| $65K | ﹤0.01% |
11,049
-148
| -1% | -$914 |
2020 Q4
1 quarter
|
|
|
CNCE
1347
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $60K | ﹤0.01% |
+12,099
| New | +$97.8K |
2021 Q1
0 quarters
|
|
|
NBRV
1348
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $55K | ﹤0.01% |
1,328
+274
| +26% | +$17K |
2020 Q2
3 quarters
|
|
1349
Transocean
RIG
$6.15B
| $54K | ﹤0.01% |
+15,075
| New | +$52.4K |
2021 Q1
0 quarters
|
|
1350
DELISTED
PHX Minerals
PHX
| $51K | ﹤0.01% |
17,603
+785
| +5% | +$2.4K |
2019 Q3
6 quarters
|
|
Similar funds
HC
Winton Group's Q1 2021 Portfolio in Review
As of Q1 2021, Winton Group held 1,497 positions worth $1.75B, up 27% from $1.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Winton Group deployed $219M of net new capital in Q1 2021, opening 198 new positions and adding to 649 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 190,876 shares worth $14M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street Consumer Discretionary Select Sector SPDR ETF, an estimated $9.87M trimmed.
- Winton Group's largest Q1 2021 buy was State Street Communication Services Select Sector SPDR ETF: 190,876 shares worth $14M.
- Winton Group added most to State Street Industrial Select Sector SPDR ETF in Q1 2021, an estimated $38.1M increase.
- Winton Group's biggest Q1 2021 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $9.87M.
- Winton Group fully exited Varian Medical Systems, Inc. in Q1 2021, selling an estimated $13.1M.
- Winton Group's ten largest holdings make up 21% of its $1.75B portfolio in Q1 2021.
- Winton Group opened 198 new positions and closed 137 in Q1 2021.
- Winton Group's portfolio value rose 27% quarter-over-quarter to $1.75B.
Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.